115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12609)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mapping, division, and inking
    Book Section

    Possum, B.; Tagliaferro, R.; Nehal, K. S.; McKay, C.; Vidal, N.; Lee, E.
    In McKay, C.; Nehal, K. S. (Eds.) Laboratory manual for mohs micrographic surgery: Frozen tissue processing (2024)

    Fulltext@MSK | Save
  • Accessioning
    Book Section

    Possum, B.; Tagliaferro, R.; Nehal, K. S.; Polansky, M.; McKay, C.
    In McKay, C.; Nehal, K. S. (Eds.) Laboratory manual for mohs micrographic surgery: Frozen tissue processing (2024)

    Fulltext@MSK | Save
  • Laboratory manual for Mohs micrographic surgery: Frozen tissue processing
    Book Whole

    McKay, C.; Nehal, K. S.
    Springer (2024)

    Fulltext@MSK | Save
  • Evaluation of cisplatin-induced acute kidney injury in patients coprescribed serotonin receptor antagonists: A retrospective analysis
    Journal Article

    Gutgarts, V.; Gerardine, S.; Shingarev, R. A.; Knezevic, A.; Zabor, E. C.; Latcha, S.; Joy, M. S.; Aleksunes, L. M.; Jaimes, E. A.
    Kidney360 (2024)

    Fulltext@MSK | Save
  • A classic article that has never been read in English
    Editorial

    Pappou, E.; Sorber, R.; Reifsnyder, T.
    Journal of Vascular Surgery Cases, Innovations and Techniques (2024)

    Fulltext@MSK | Save
  • A promising step forward with giant leaps ahead
    Editorial

    Shaverdian, N.; Li, B. T.; Isbell, J.; Chaft, J. E.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in ALK-positive NSCLC with prior ALK inhibitor resistance
    Journal Article

    Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Three-year overall survival outcomes and correlative analyses in patients with NSCLC and high (50%–89%) versus very high (≥90%) programmed death-ligand 1 expression treated with first-line pembrolizumab or cemiplimab
    Journal Article

    Ricciuti, B.; Elkrief, A.; Lin, J.; Zhang, J.; Alessi, J. V.; Lamberti, G.; Gandhi, M.; Di Federico, A.; Pecci, F.; Wang, X.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
    Journal Article

    Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
    Journal Article

    Fontana, E.; Rosen, E.; Lee, E. K.; Højgaard, M.; Mettu, N. B.; Lheureux, S.; Carneiro, B. A.; Cote, G. M.; Carter, L.; Plummer, R.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save